Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/21831
Title: Oxygen therapy in COPD and interstitial lung disease: navigating the knowns and unknowns.
Authors: Khor, Yet H;Renzoni, Elisabetta A;Visca, Dina;McDonald, Christine F;Goh, Nicole S L
Affiliation: School of Medicine, University of Melbourne, Melbourne, Australia
Interstitial Lung Disease Unit, Royal Brompton Hospital, Imperial College London, London, UK
Dept of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Australia
Institute for Breathing and Sleep, Austin Health, Heidelberg, Victoria, Australia
Dept of Respiratory Medicine, Alfred Health, Melbourne, Australia
Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy Dept of Medicine and Surgery, Respiratory Diseases, University of Insubria, Varese-Como, Italy
Issue Date: Jul-2019
EDate: 2019
Citation: ERJ open research 2019; 5(3): 00118-2019
Abstract: Domiciliary oxygen therapy is often prescribed for patients with hypoxaemia due to advanced lung disease, most commonly chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD). Long-term oxygen therapy (LTOT) trials conducted in patients with COPD in the 1980s remain the basis for clinical decisions and guideline recommendations regarding LTOT for patients with non-COPD conditions as there is a lack of high-quality evidence concerning its use in the non-COPD population. There is also a lack of evidence for the use of ambulatory and nocturnal oxygen therapy in patients with isolated exertional and nocturnal hypoxaemia. These deficiencies pose significant challenges in patient care, with consequent discrepancies in guideline recommendations and clinical approaches. In recent years, new studies have been and are currently being conducted to fill the gaps in our understanding and use of domiciliary oxygen therapy for other indications, including ILD. This article provides a comparison of the epidemiology and significance of hypoxaemia in patients with COPD and ILD, with an up-to-date review of current evidence regarding the role of different types of domiciliary oxygen therapy in these conditions.
URI: http://ahro.austin.org.au/austinjspui/handle/1/21831
DOI: 10.1183/23120541.00118-2019
ORCID: 0000-0002-5434-9342
0000-0003-2298-1623
0000-0001-6481-3391
PubMed URL: 31544111
ISSN: 2312-0541
Type: Journal Article
Review
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.